Literature DB >> 12538079

Hormonal modulation of delta6 and delta5 desaturases: case of diabetes.

Rodolfo R Brenner1.   

Abstract

Animal biosynthesis of high polyunsaturated fatty acids from linoleic, alpha-linolenic and oleic acids is mainly modulated by the delta6 and delta5 desaturases through dietary and hormonal stimulated mechanisms. From hormones, only insulin activates both enzymes. In experimental diabetes mellitus type-1, the depressed delta6 desaturase is restored by insulin stimulation of the gene expression of its mRNA. However, cAMP or cycloheximide injection prevents this effect. The depression of delta6 and delta5 desaturases in diabetes is rapidly correlated by lower contents of arachidonic acid and higher contents of linoleic in almost all the tissues except brain. However, docosahexaenoic n-3 acid enhancement, mainly in liver phospholipids, is not explained yet. In experimental non-insulin dependent diabetes, the effect upon the delta6 and delta5 desaturases is not clear. From all other hormones glucagon, adrenaline, glucocorticoids, mineralocorticoids, oestriol, oestradiol, testosterone and ACTH depress both desaturases, and a few hormones: progesterone, cortexolone and pregnanediol are inactive.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538079     DOI: 10.1016/s0952-3278(02)00265-x

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  53 in total

1.  A Polymer Coating Transfer Enrichment Method for Direct Mass Spectrometry Analysis of Lipids in Biofluid Samples.

Authors:  Wenpeng Zhang; Spencer Chiang; Zishuai Li; Qinhua Chen; Yu Xia; Zheng Ouyang
Journal:  Angew Chem Int Ed Engl       Date:  2019-03-27       Impact factor: 15.336

2.  The fatty acid desaturase 2 (FADS2) gene product catalyzes Δ4 desaturation to yield n-3 docosahexaenoic acid and n-6 docosapentaenoic acid in human cells.

Authors:  Hui Gyu Park; Woo Jung Park; Kumar S D Kothapalli; J Thomas Brenna
Journal:  FASEB J       Date:  2015-06-11       Impact factor: 5.191

3.  Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study.

Authors:  E Corpeleijn; E J M Feskens; E H J M Jansen; M Mensink; W H M Saris; T W A de Bruin; E E Blaak
Journal:  Diabetologia       Date:  2006-08-03       Impact factor: 10.122

4.  Determinants of Blood Cell Omega-3 Fatty Acid Content.

Authors:  Robert C Block; William S Harris; James V Pottala
Journal:  Open Biomark J       Date:  2008

Review 5.  The Potential Role of Fatty Acids in Treating Diabetic Neuropathy.

Authors:  Mark A Yorek
Journal:  Curr Diab Rep       Date:  2018-08-25       Impact factor: 4.810

6.  Anti-inflammatory nutrition as a pharmacological approach to treat obesity.

Authors:  Barry Sears; Camillo Ricordi
Journal:  J Obes       Date:  2010-09-30

7.  Fads1 and 2 are promoted to meet instant need for long-chain polyunsaturated fatty acids in goose fatty liver.

Authors:  Rashid H Osman; Long Liu; Lili Xia; Xing Zhao; Qianqian Wang; Xiaoxian Sun; Yihui Zhang; Biao Yang; Yun Zheng; Daoqing Gong; Tuoyu Geng
Journal:  Mol Cell Biochem       Date:  2016-06-25       Impact factor: 3.396

8.  Association of plasma ω-3 and ω-6 lipids with burden of disease measures in bipolar subjects.

Authors:  Simon J Evans; Masoud Kamali; Alan R Prossin; Gloria J Harrington; Vicki L Ellingrod; Melvin G McInnis; Charles F Burant
Journal:  J Psychiatr Res       Date:  2012-08-11       Impact factor: 4.791

9.  Desaturase activities in rat model of insulin resistance induced by a sucrose-rich diet.

Authors:  Rodolfo R Brenner; Omar J Rimoldi; Yolanda B Lombardo; María S González; Ana M Bernasconi; Adriana Chicco; Juan C Basabe
Journal:  Lipids       Date:  2003-07       Impact factor: 1.880

10.  Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder.

Authors:  Robert K McNamara
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.